Viemed Healthcare, Inc. (VMD) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.1	$0.07	-30.0%	—	$78.1M	—
Q1 26	$0.09	$0.06	-33.3%	—	$75.4M	—
Q4 25	$0.13	$0.14	+7.7%	—	$76.2M	—
Q3 25	$0.09	$0.09	0.0%	—	$71.9M	—
Q2 25	$0.09	$0.08	-11.1%	—	$63.1M	—
Q1 25	$0.06	$0.06	0.0%	—	$59.1M	—
Q4 24	$0.1	$0.1	0.0%	—	$60.7M	—
Q3 24	$0.06	$0.1	+66.7%	—	$58M	—
Q2 24	$0.07	$0.08	+14.3%	—	$55M	—
Q1 24	$0.07	$0.04	-42.9%	—	$50.6M	—
Q4 23	$0.09	$0.09	0.0%	—	$50.7M	—
Q3 23	$0.09	$0.07	-22.2%	—	$49.4M	—
Q2 23	$0.05	$0.06	+20.0%	—	$43.3M	—
Q1 23	$0.04	$0.04	0.0%	—	$39.6M	—
Q4 22	$0.04	$0.06	+50.0%	—	$37.5M	—
Q3 22	$0.05	$0.03	-40.0%	—	$35.8M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$0.38	—	—	$270.3M	—
FY24	—	$0.29	—	—	$224.3M	—
FY23	—	$0.27	—	—	$183M	—
FY22	—	$0.16	—	—	$138.8M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$31.4M	$46.9M	$64.5M	$80.3M	$131.3M	$117.1M	$138.8M	$183M	$224.3M	$270.3M
YoY change	—	+49.7%	+37.4%	+24.5%	+63.6%	-10.8%	+18.6%	+31.8%	+22.5%	+20.5%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	31.4M	46.9M	64.5M	80.3M	131.3M	117.1M	138.8M	183M	224.3M	270.3M
Cost of revenue	12.5M	12.3M	16.7M	24.3M	51.2M	43.7M	54.2M	70.2M	91.1M	114.8M
Gross profit	18.9M	34.6M	47.8M	56M	80.1M	73.4M	84.7M	112.8M	133.2M	155.5M
Gross margin	60.1%	73.8%	74.1%	69.8%	61%	62.7%	61%	61.6%	59.4%	57.5%
Research & development	—	—	0	848K	1.1M	2.1M	2.7M	2.8M	3.1M	3M
Selling, general & administrative	13.8M	20.2M	37M	45.3M	57.7M	60M	73.4M	93.7M	112.5M	130.5M
Operating expenses	13.8M	25.4M	43.2M	46.1M	54.8M	60.5M	75.1M	96.4M	115.7M	133.3M
Operating income	4.8M	14M	10.2M	9.2M	24.5M	12M	8.6M	15M	16M	20.7M
Operating margin	15.2%	29.8%	15.8%	11.5%	18.6%	10.3%	6.19%	8.18%	7.13%	7.66%
Non-operating income, net	-4.3M	-5.5M	-330K	-107K	2.4M	793K	589K	-160K	951K	2.2M
Pretax income	109K	8.2M	9.7M	8.8M	26.4M	12.5M	9M	14.4M	16.2M	21.8M
Income tax	-1.1M	15K	162K	271K	-5.2M	3.4M	2.8M	4.1M	4.8M	6.4M
Net income	1.2M	8.2M	9.5M	8.5M	31.5M	9.1M	6.2M	10.2M	11.4M	15.4M
Net margin	3.92%	17.4%	14.7%	10.6%	24%	7.8%	4.48%	5.6%	5.09%	5.69%
EBITDA	6.2M	16.5M	14M	15.5M	34.1M	24.6M	25.2M	37.3M	40.4M	49.3M
EPS	0.03	0.22	0.25	0.23	0.81	0.23	0.16	0.27	0.29	0.38
Diluted EPS	0.03	0.22	0.24	0.21	0.78	0.22	0.16	0.25	0.28	0.37

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	49.4M	50.7M	50.6M	55M	58M	60.7M	59.1M	63.1M	71.9M	76.2M	75.4M	78.1M
Cost of revenue	18.8M	18.6M	20.8M	22.1M	23.6M	24.6M	25.9M	26.3M	30.6M	32.1M	32.6M	33M
Gross profit	30.6M	32.1M	29.8M	32.9M	34.4M	36.1M	33.3M	36.7M	41.3M	44.1M	42.8M	45M
Gross margin	61.9%	63.3%	58.9%	59.8%	59.3%	59.5%	56.3%	58.3%	57.5%	57.9%	56.8%	57.7%
Research & development	593K	651K	750K	758K	757K	803K	797K	847K	775K	598K	579K	504K
Selling, general & administrative	25.1M	25.4M	26.2M	28.1M	28.4M	29.7M	30.7M	31.1M	34.1M	34.5M	37.2M	39.2M
Operating expenses	25.7M	26.1M	27M	29.4M	28.9M	30.4M	31.5M	31.9M	34.8M	35.1M	37.8M	39.6M
Operating income	4.5M	5.6M	2.4M	3.1M	5.2M	5.3M	1.5M	4.5M	6.1M	8.7M	4.7M	5.1M
Operating margin	9.08%	11%	4.78%	5.59%	8.89%	8.81%	2.49%	7.07%	8.51%	11.4%	6.17%	6.48%
Non-operating income, net	-8K	-229K	-146K	-572K	565K	1.1M	2.4M	636K	-476K	-289K	-356K	-760K
Pretax income	4.2M	5.1M	2.1M	2.2M	5.5M	6.3M	3.7M	5M	5.1M	8M	4M	4.1M
Income tax	1.3M	1.6M	518K	768K	1.6M	1.9M	952K	1.7M	1.5M	2.2M	1.3M	1.2M
Net income	2.9M	3.5M	1.6M	1.5M	3.9M	4.4M	2.7M	3.3M	3.6M	5.8M	2.7M	2.9M
Net margin	5.91%	6.85%	3.17%	2.69%	6.73%	7.29%	4.58%	5.15%	5.01%	7.63%	3.6%	3.71%
EBITDA	10.7M	11.5M	8.8M	8.8M	11.7M	11.7M	8.1M	10.7M	13.7M	16.2M	12.3M	13.3M
EPS	0.08	—	0.04	0.04	0.1	0.11	0.07	0.08	0.09	0.15	0.07	0.07
Diluted EPS	0.07	—	0.04	0.04	0.1	0.1	0.06	0.08	0.09	0.14	0.06	0.07

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	—	—	—	233.8M	300.6M	206.1M	292.2M	301.1M	310.8M	289M	347M
Enterprise value	—	—	—	240M	280.8M	184.3M	276M	298.6M	300.1M	291.4M	342.2M
Shares outstanding	37.9M	37.9M	37.9M	37.7M	38.7M	39.5M	38.7M	38.4M	38.8M	38.9M	38.9M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	—	—	27.4	9.54	22.6	47	29.4	27.2	18.8	24.7
P/S	—	—	—	2.91	2.29	1.76	2.1	1.65	1.39	1.07	1.13
P/B	—	—	—	5.35	3.68	2.17	3.01	2.64	2.33	2.01	2.36
EV/EBITDA	—	—	—	15.5	8.23	7.5	11	8	7.43	5.91	6.13
EV/Sales	—	—	—	2.99	2.14	1.57	1.99	1.63	1.34	1.08	1.14
Earnings yield	—	—	—	3.65%	10.5%	4.43%	2.13%	3.4%	3.67%	5.32%	4.04%
FCF yield	—	—	—	2.44%	7.34%	1.33%	1.66%	6.35%	0.42%	4.13%	8.15%
PEG	—	—	—	—	—	—	—	—	—	—	-1.98

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	60.1%	73.8%	74.1%	69.8%	61%	62.7%	61%	61.6%	59.4%	57.5%	57.7%
Operating margin	15.2%	29.8%	15.8%	11.5%	18.6%	10.3%	6.19%	8.18%	7.13%	7.66%	6.48%
Net margin	3.92%	17.4%	14.7%	10.6%	24%	7.8%	4.48%	5.6%	5.09%	5.69%	4.81%
ROE	9.53%	34.4%	29.2%	19.5%	38.6%	9.62%	6.41%	8.99%	8.56%	10.7%	10.5%
ROA	4.98%	21.7%	17.7%	10.3%	28%	7.74%	5.32%	6.61%	6.44%	7.72%	8.21%
ROIC	31.7%	58.5%	39.1%	17.9%	39.5%	12%	7.36%	9.57%	9.2%	10%	11.8%
Return on tangible assets	4.98%	21.7%	17.7%	10.3%	28%	7.74%	5.32%	10.9%	10.4%	19.5%	17.9%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.22	1.29	1.18	1.07	2.05	2.66	2.11	1.19	1.42	1.18	1.13
Quick ratio	1.04	1.17	1.03	1.02	1.95	2.52	1.92	1.05	1.3	1.06	1.02
Debt / equity	0.5	0.22	0.11	0.45	0.14	0.07	0.01	0.09	0.05	0.11	0.08
Debt / assets	0.26	0.14	0.06	0.24	0.1	0.06	0.01	0.07	0.04	0.08	0.06
Net debt / EBITDA	0.35	0	-0.5	0.4	-0.58	-0.89	-0.64	-0.07	-0.26	0.05	0.02
Interest coverage	1.34	31.1	54.4	29	52.8	40.3	46.6	34.9	21.8	19.4	19.4
Effective tax rate	0%	0.18%	1.68%	3.08%	0%	27%	30.8%	28.8%	29.4%	29.4%	29.1%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	0.83	1.24	1.7	2.13	3.39	2.96	3.59	4.77	5.79	6.95	7.87
EPS (basic)	0.03	0.22	0.25	0.23	0.81	0.23	0.16	0.27	0.29	0.38	0.38
EPS (diluted)	0.03	0.22	0.24	0.21	0.78	0.22	0.16	0.25	0.28	0.37	0.36
Book value per share	0.34	0.63	0.86	1.16	2.11	2.4	2.51	2.97	3.44	3.69	3.78
FCF per share	0.13	0.21	0.43	0.15	0.57	0.07	0.13	0.5	0.03	0.31	0.71
Cash per share	0.11	0.13	0.27	0.35	0.8	0.72	0.44	0.33	0.45	0.35	0.28
Capex per share	0.02	0.09	0.14	0.34	0.2	0.48	0.56	0.61	0.71	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	2.99%	7.61%	8.22%	16%	5.93%	16.4%	15.7%	12.8%	12.2%	—	—
Capex / operating cash flow	32.8%	158.1%	42.6%	170.7%	30.5%	95%	75.4%	63.6%	72.8%	—	—
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$49.4M	$50.7M	$50.6M	$55M	$58M	$60.7M	$59.1M	$63.1M	$71.9M	$76.2M	$75.4M	$78.1M
YoY change	+38.2%	+35.3%	+27.9%	+26.9%	+17.4%	+19.6%	+16.9%	+14.7%	+24%	+25.5%	+27.5%	+23.9%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	4.3M	5.1M	10.4M	13.4M	31M	28.4M	16.9M	12.8M	17.5M	13.5M
Receivables	4.8M	9.8M	8.8M	11.5M	12.4M	12.8M	15.4M	18.5M	24.9M	25.6M
Inventory	1.6M	1.6M	2.9M	1.4M	2.3M	2.5M	3.6M	4.6M	4.3M	5M
Total current assets	11.2M	17M	23.1M	27.8M	47.2M	47.3M	39.7M	38.4M	52.9M	48.5M
Property, plant & equipment	13.5M	20.7M	30.3M	48.4M	49.1M	55.2M	61.4M	68.9M	70.9M	73.9M
Goodwill & intangibles	—	—	—	—	—	—	0	60.7M	67.7M	120.4M
Total assets	24.7M	37.7M	53.7M	82.6M	112.6M	118M	117M	154.9M	177.1M	199.2M
Accounts payable	1.9M	3.4M	6.8M	5.7M	3.3M	5.3M	4.9M	7.4M	9.3M	12.3M
Short-term debt	3.9M	4.4M	3M	8.8M	4.6M	1.9M	495K	2M	1.3M	2.3M
Total current liabilities	9.2M	13.1M	19.6M	25.9M	23M	17.8M	18.9M	32.1M	37.3M	41.1M
Long-term debt	2.6M	798K	394K	10.7M	6.6M	4.6M	199K	8.3M	5.6M	13.7M
Total liabilities	11.8M	13.9M	21.1M	38.9M	30.9M	23.1M	19.9M	41M	43.8M	55.6M
Shareholders' equity	12.9M	23.7M	32.6M	43.7M	81.7M	94.8M	97.1M	113.9M	133.3M	143.5M
Total debt	6.5M	5.2M	3.4M	19.5M	11.1M	6.5M	694K	10.3M	6.9M	15.9M
Net debt	2.2M	81K	-7M	6.2M	-19.8M	-21.9M	-16.2M	-2.5M	-10.7M	2.4M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	10.1M	12.8M	7.3M	8.8M	11.3M	17.5M	10.2M	20M	11.1M	13.5M	9.8M	10.7M
Receivables	17.9M	18.5M	24.5M	27.1M	27.1M	24.9M	26.8M	26.5M	27.4M	25.6M	31.2M	32.2M
Inventory	4.7M	4.6M	4.3M	4.4M	4.3M	4.3M	4.5M	4.3M	5.3M	5M	5.2M	5.3M
Total current assets	35.9M	38.4M	38.6M	45M	47.7M	52.9M	49.1M	55.3M	50M	48.5M	49.8M	54M
Property, plant & equipment	67.3M	68.9M	68.6M	69.7M	69.1M	70.9M	75.6M	74M	75.6M	73.9M	70.7M	73.1M
Goodwill & intangibles	60.8M	60.7M	60.6M	67.8M	67.7M	67.7M	67.6M	67.5M	119.6M	120.4M	120.3M	120.2M
Total assets	149.4M	154.9M	154.9M	163.9M	169.5M	177.1M	178.1M	184.6M	202.4M	199.2M	197.4M	204.2M
Accounts payable	9.3M	7.4M	8.8M	10.2M	10.1M	9.3M	12.6M	12.6M	14.4M	12.3M	13.4M	17M
Short-term debt	2.4M	2M	1.5M	1.6M	1.6M	1.3M	1.3M	1.7M	2.7M	2.3M	2.1M	2.1M
Total current liabilities	31.6M	32.1M	30.1M	31.5M	36.4M	37.3M	35.5M	37.3M	44.2M	41.1M	40.7M	47.9M
Long-term debt	8.5M	8.3M	8M	10.8M	5.6M	5.6M	5.4M	5.2M	22M	13.7M	10.4M	9.5M
Total liabilities	40.6M	41M	38.6M	42.8M	42.7M	43.8M	41.3M	43M	66.9M	55.6M	51.6M	58.3M
Shareholders' equity	108.8M	113.9M	116.3M	121.2M	126.8M	133.3M	136.7M	141.6M	135.5M	143.5M	145.8M	146M
Total debt	10.9M	10.3M	9.5M	12.5M	7.3M	6.9M	6.8M	6.9M	24.7M	15.9M	12.4M	11.6M
Net debt	821K	-2.5M	2.2M	3.7M	-4.1M	-10.7M	-3.4M	-13.1M	13.6M	2.4M	2.7M	920K

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	1.2M	8.2M	9.5M	8.5M	31.5M	9.1M	6.2M	10.2M	11.4M	15.4M
Depreciation & amortization	1.4M	2.5M	3.8M	6.4M	9.6M	11.3M	15.6M	21.9M	25.4M	28.6M
Stock-based compensation	0	828K	2.7M	3.9M	4.9M	5.2M	5.2M	5.8M	6.3M	9.1M
Change in working capital	205K	-9.3M	-3.5M	-11.3M	-11.7M	-9.3M	165K	641K	-3M	-2.1M
Operating cash flow	2.9M	2.3M	12.5M	7.5M	25.6M	20.2M	29M	36.9M	37.7M	51.9M
Capital expenditure	-936K	-3.6M	-5.3M	-12.8M	-7.8M	-19.1M	-21.8M	-23.5M	-27.4M	—
Investing cash flow	-936K	-3.6M	-5.3M	-12.8M	-8.4M	-19.7M	-24M	-52.1M	-30.7M	-26.3M
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	0	-1.6M	-1.5M	0	-1.4M	-9.7M	-594K	-1.1M	-15M
Financing cash flow	-4.3M	-7.7M	-11.8M	-3.7M	-10.9M	-5.4M	-15.5M	-5.5M	-4.7M	-7.2M
Net change in cash	-2.4M	-9M	-4.6M	-9M	6.2M	-5M	-10.6M	-20.7M	2.3M	18.4M
Free cash flow	4.7M	8M	16.3M	5.7M	22.1M	2.8M	4.8M	19.1M	1.3M	11.9M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	2.9M	3.5M	1.6M	1.5M	3.9M	4.4M	2.7M	3.3M	3.6M	5.8M	2.7M	2.9M
Depreciation & amortization	6M	5.9M	6.3M	6.3M	6.4M	6.4M	6.6M	6.9M	7.5M	7.6M	7.6M	7.5M
Stock-based compensation	1.5M	1.5M	1.4M	1.6M	1.7M	1.5M	2.3M	2.3M	2.2M	2.3M	2.5M	2M
Change in working capital	1.5M	825K	-4.8M	-4.1M	2.4M	3.4M	-2.8M	818K	-3.3M	3.2M	-2.9M	671K
Operating cash flow	11.8M	11.1M	4.5M	6.7M	12.3M	15.5M	8.9M	12.3M	18.4M	18.4M	8.1M	15.9M
Capital expenditure	-7M	-7.5M	-5.4M	-8.2M	-5M	-8.9M	-8.5M	—	—	—	—	—
Investing cash flow	-8.5M	-7.5M	-5.4M	-8.2M	-5M	-9.9M	-8.5M	—	-26.3M	0	—	—
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	-69K	1K	-961K	-11K	-93K	-4K	-1.6M	-1.7M	-11.7M	-2K	-3.4M	-5.4M
Financing cash flow	-17.5M	-5.1M	-1.6M	-387K	-5.3M	-197K	-1.7M	-1.8M	5M	-8.5M	-6.9M	-7.7M
Net change in cash	-14.2M	-1.5M	-2.5M	-1.9M	2M	5.3M	-1.4M	10.4M	-3M	10M	1.2M	8.2M
Free cash flow	6.4M	5.4M	-4.8M	1.2M	1.7M	3.2M	-12.6M	4.1M	10.7M	9.7M	1.4M	7.4M

Viemed Healthcare, Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement